Teva Pharmaceuticals USA recalls Lidocaine Patch 5% (700 mg) ,(NDC 0591-3525-11), 30 envelopes containing 1 patch each/ 30 Patches/Carton (NDC 0591-3525…
- Recall date
- April 30, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0857-2018
- FDA classification
- Class III
- Brand / firm
- Teva Pharmaceuticals USA
- Sold / distributed
- United States
Why it was recalled
Failed Stability Specifications
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Lidocaine Patch 5% (700 mg) ,(NDC 0591-3525-11), 30 envelopes containing 1 patch each/ 30 Patches/Carton (NDC 0591-3525-30)
Get recall alerts
Free email alert whenever Teva Pharmaceuticals USA has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Teva Pharmaceuticals USA